EUVIMEDEUVIMED entdecken
Crossref

Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population‐based cancer registry study

Ariana Znaor iD, Sultan Eser, Karima Bendahhou, Wael Shelpai, Najla Al Lawati, Amani ELBasmi, Elias Mamo Alemayehu, Mohammed Adnane Tazi, Cankut Yakut, Marion Piñeros iD

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Ariana Znaor und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Registries, Colorectal Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the 2nd most common cancer and 3rd most common cause of death in the Middle East and Northern Africa (MENA) region. We aimed to explore CRC stage at diagnosis data from population‐based cancer registries in MENA countries. In 2021, we launched a Global Initiative for Cancer Registry Development (GICR) survey on staging practices and breast and CRC stage distributions in MENA. According to the survey results, population‐based data on TNM stage for CRC were available from six registries in five countries (Kuwait, Morocco, Oman, Türkiye, UAE). The proportion of cases with unknown TNM stage ranged from 14% in Oman to 47% in Casablanca, Morocco. The distribution of CRC cases with known stage showed TNM stage IV proportions of 26–45%, while the proportions of stage I cancers were lowest in Morocco (≤7%), and highest (19%) in Izmir, Türkiye. Summary extent of disease data was available from six additional registries and four additional countries (Algeria, Bahrain, Iraq, Qatar). In summary, the proportions of CRC diagnosed with distant metastases in Oman, Bahrain and UAE were lower than other MENA countries in our study, but higher than in European and the US populations. Harmonising the use of staging systems and focusing stage data collection efforts on major cancers, such as CRC, is needed to monitor and evaluate progress in CRC control in the region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesColorectal NeoplasmsNeoplasm StagingHumansMiddle EastAfrica, NorthernFemaleMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

MENAcolorectal cancerpopulation‐based cancer registrystage at diagnosis

Autor:innen und Institutionen

  • Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
  • Faculty of Medicine, Balikesir University, Balikesir, Türkiye.
  • Casablanca Cancer Registry, Casablanca, Morocco.
  • National Cancer Registry, Dubai, United Arab Emirates.
  • Oman National Cancer Registry, Muscat, Oman.
  • Kuwait National Cancer Registry, Kuwait City, Kuwait.

ORCID-Profile: Ariana Znaor, Marion Piñeros

Förderung

  • World Health Organization

Zitieren

APA

Znaor, A., Eser, S., Bendahhou, K., Shelpai, W., Al Lawati, N., ELBasmi, A., Alemayehu, E. M., Tazi, M. A., Yakut, C., & Piñeros, M. (2024). Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population‐based cancer registry study. International Journal of Cancer. https://doi.org/10.1002/ijc.34895

Vancouver

Znaor A, Eser S, Bendahhou K, Shelpai W, Al Lawati N, ELBasmi A, et al. Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population‐based cancer registry study. International Journal of Cancer. 2024. doi:10.1002/ijc.34895

BibTeX
@article{Znaor2024,
  author = {Znaor, Ariana and Eser, Sultan and Bendahhou, Karima and Shelpai, Wael and Al Lawati, Najla and ELBasmi, Amani and Alemayehu, Elias Mamo and Tazi, Mohammed Adnane and Yakut, Cankut and Piñeros, Marion},
  title = {Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population‐based cancer registry study},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34895}
}
Kostenlos starten →